Abstract
Calcium phosphate (CaP) nanomaterials are considered as potential biomaterial for drug delivery systems because of their excellent biocompatible features. In the present study, amino glycoside antibiotics, such as kanamycin and gentamycin-loaded CaP nanoparticles, were successfully synthesized by the precipitation method. Physicochemical properties were analyzed by XRD, FTIR, FE-SEM, EDX, and light-scattering (DLS) measurements. The average size of CaP nanoparticles ranges from 20 to 100 nm, as measured by DLS analysis. The crystallinity of the prepared nanoparticles was confirmed by XRD analysis, which revealed that the CaP nanoparticles were in crystalline and hydroxyapatite (HA) phase with tricalcium phosphate (TCP). The FTIR spectrum confirmed the presence of phosphate and surface hydroxyl groups. In vitro release study of drug-loaded CaP (D-CaP) nanoparticles was performed, and the drug release from nanoparticles was sustained over 5 days, with an entrapment efficiency of 52.05 ± 3% and 65.3 ± 4%, respectively. The antibacterial activity of D-CaP nanoparticles was evaluated against Bacillus cereus (KACC 14394), Staphylococcus aureus (KCTC 1916) Escherichia coli (KACC 10005), and Salmonella typhi (KCCM 40253) by the well diffusion and minimum inhibitory concentration (MIC) methods. We found the bactericidal effect of D-CaP nanoparticles in a dose-dependent manner by MTT assay. In addition, the interaction of D-CaP nanoparticles against bacterial pathogens was demonstrated by Bio-TEM analysis, providing clear evidence of the disruption of bacterial cell membranes. The results of the present study suggest that D-CaP nanoparticles can be useful for the treatment of bacterial infection in the bone as well as in the biomedical field.
Similar content being viewed by others
References
S. Weiner and L. Addadi (1997). J. Mater. Chem. 7, 89–702.
M. Vallet-Regi and J. M. Gonzalez-Calbet (2004). Prog. Solid State Chem. 32, 1–31.
L. L. Hench and J. M. Polak (2002). Third-generation biomedical materials. Science 295, 1014–1017.
A. Veis (2005). A window on biomineralization. Science 307, 1419–1420.
K. Kurashina (1997). Biomaterials 18, 539–543.
D. Apelt, F. Theiss, A. O. El-Warrak, K. Zlinszky, R. Bettschart-Wolfisberger, M. Bohner, S. Matter, J. A. Auer, and B. Von Rechenberg (2004). Biomaterials 25, 1439–1451.
J. A. Jansen, J. E. de Ruijter, H. G. Schaeken, J. P. C. Van der Waerden, J. A. Planell, and F. C. M. Driessens (1995). J. Mater. Sci. Mater. Med. 6, 653–657.
C. D. Friedman, P. D. Costantino, S. Takagi, and L. C. Chow (1998). J. Biomed. Mater. Res. Appl. Biomater. 43, 428–432.
S. Larsson and T. W. Bauer (2002). Clin. Orthop. Relat. Res. 395, 23–32.
E. M. Ooms, J. G. C. Wolke, M. T. Van de Heuvel, B. Jeschke, and J. A. Jansen (2003). Biomaterials 24 (6), 989–1000.
P. Torner (2001). Bone tissue repair by osteotransduction with a calcium phosphate cement. An experimental study. PhD Thesis from the Dept of Surgery, Faculty of Medicine. Universitat de Barcelona 2001: Spain.
E. Fernández, M. G. Boltong, M. P. Ginebra, F. C. M. Driessens, O. Bermúdez, and J. A. Planell (1996). J. Mater. Sci. Lett. 15, 1004–1005.
A. E. Ewence, M. Bootman, H. L. Roderick, J. N. Skepper, G. McCarthy, M. Epple, M. Neumann, C. M. Shanahan, and D. Proudfoot (2008). Circ. Res. 103, e28.
A. Doat, F. Pelle, N. Gardant, and A. J. Lebugle (2004). Solid State Chem. 177, 1179–1187.
S. Padilla Mondejar, A. Kovtun, and M. Epple (2007). J. Mater. Chem. 17, 4153–4159.
M. Kester, Y. Heakal, T. Fox, A. Sharma, G. P. Robertson, T. T. Morgan, E. I. Altinoglu, A. Tabakovic, M. R. Parette, S. M. Rouse, V. RuizVelasco, and J. H. Adair (2008). Nano Lett. 8, 4116–4121.
X. Cheng and L. Kuhn (2007). Int. J. Nanomed. 2, 667–674.
R. Ramachandran, W. Paul, and C. P. Sharma (2009). J. Biomed. Mater. Res. Part B 88, 41–48.
A. Salama and M. El-Sakhawy (2014). Carbohydr. Polym. 113, 500–506.
Z. F. Zhou, T. W. Sun, F. Chen, D. Q. Zuo, H. S. Wang, Y. Q. Hua, Z. D. Cai, and J. Tan (2017). Biomaterials 121, 1–14.
S. Wang, X. Wang, H. Xu, H. Abe, Z. Tan, Y. Zhao, J. Guo, M. Naito, H. Ichikawa, and Y. Fukumori (2010). Adv. Powder Technol. 21, 268–272.
T. Cao, W. Tang, J. Zhao, L. Qin, and C. Lan (2014). J. Bionic Eng. 11, 125–133.
D. Guo, D. Dou, L. Ge, Z. Huang, L. Wang, and N. Gu (2015). A caffeic acid mediated facile synthesis of silver nanoparticles with powerful anti-cancer activity. Colloid Surf. B: Biointerfaces 134, 229–234.
S. Erdogan, K. Turkekul, R. Serttas, and Z. Erdogan (2017). Biomed. Pharmacother. 88, 210–217.
V. Vergaro, P. Papadia, P. Petrini, F. P. Fanizzi, S. A. De Pascali, F. Baldassarre, L. Pastorino, and G. Ciccarella (2017). Int. J. Biol. Macromol. 99, 187–95.44.
T. Liu, A. Tang, G. Y. Zhang, Y. X. Chen, J. Y. Zhang, S. S. Peng, and Z. M. Cai (2005). Cancer Biother. Radiopharm. 20, 141–149.
A. Qadir, Y. Gao, P. Suryaji, Y. Tian, X. Lin, K. Dang, S. Jiang, Y. Li, Z. Miao, and A. Qian (2019). Non-viral delivery system and targeted bone disease therapy. Int. J. Mol. Sci. 20, 565.
D. N. Gilbert, G. L. Mandell, J. E. Bennett, and R. Dolin (1995). Principles and Practice of Infectious Diseases, 4th ed. New York: Churchill Livingstone.
K. Lin, J. Chang, R. Cheng, and M. Ruan (2007). Mater. Lett. 61, 1683–1687.
F. Barrère, C. A. Van Blitterswijk, and K. de Groot (2006). Int. J. Nanomed. 1 (3), 317–332.
B. D. Cullity, in M. Cohen (ed.) (1977). Elements of X-ray Diffraction, 2nd ed. Addison-Wesley Publishing company.
V. Wu, S. Tang, and V. Uskokovic (2018). ACS Appl. Mater. Interfaces 10 (40), 34013–34028.
N. Yael Slavin, J. Asnis, O. Urs Häfeli, and H. Bach (2017). J. Nanobiotechnol. 15, 65.
G. Tortora, R. B. Funke, and L. C. Case (2001). Microbiology: An Introduction. New York: Addison-Weslay Longman Inc.
S. Pal, Y. K. Tak, and J. M. Song (2007). Does the Antibacterial Activity of Silver Nanoparticles Depend on the Shape of the Nanoparticle? A Study of the Gram-Negative Bacterium Escherichia coli. Appl. Environ. Microbiol. 73, 1712–1720.
A. C. Kassab, K. Xu, E. B. Denkbas, Y. Dou, S. Zhao, and E. Piskin (1997). Rifampicin carrying polyhydroxybutyrate microspheres as potential chemoembolization agent. J. Biomater. Sci. 8, 947–961.
M. E. Samberg, P. E. Orndorff, and N. A. Monteiro-Riviere (2011). Nanotoxicology. 5, 244–253.
X. H. N. Xu, W. J. Brownlow, S. V. Kyriacou, Q. Wan, and J. J. Viola (2004). Biochemistry. 43, 10400–10413.
D. M. Eby, H. R. Luckari, and G. R. Johnson (2009). ACS Appl. Mater. Interfaces 1, 553–1560.
J. R. Morones, J. L. Elechiguerra, A. Camacho, K. Holt, J. B. Kouri, J. T. Ramírez, and M. J. Yacaman (2005). Nanotechnology 16, 2346–2353.
C. N. Lok, C. M. Ho, R. Chen, Q. Y. He, W. Y. Yu, H. Sun, P. K. H. Tam, J. F. Chiu, and C. M. Che (2006). J. Proteome Res. 5, 916–924.
V. K. Sharma, R. A. Yngard, and Y. Lin (2009). Silver nanoparticles: green synthesis and their antimicrobial activities. Adv. Colloid Interface Sci. 145, 83–96.
J. P. Ruparelia, A. K. Chatterjee, S. P. Duttagupta, and S. Mukherji (2008). Acta Biomater. 4, 707–716.
A. Nel, T. Xia, L. M. Adler, and N. Li (2006). Science 311, 622–627.
X. Cai, B. Han, Y. Liu, F. Tian, F. Liang, and X. Wang (2017). ACS Appl. Mater. Interfaces 9, 12949–12958.
Y. Ding, K. Zhai, P. Pei, Y. Lin, H. Zhu, M. Shao, X. Yang, and W. Tao (2017). J. Colloid Interface Sci. 493, 181–189.
Acknowledgements
This work was supported by the Department of Science and Technology, India, under the scheme of DST-WOS-A, SR/WOS-A/LS-244/2016 New Delhi, India.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sathya, S., Lim, Y.T., Parthasarathi, S. et al. Fabrication of Drug-Loaded Calcium Phosphate Nanoparticles: An Investigation of Microbial Toxicity. J Clust Sci 33, 2009–2018 (2022). https://doi.org/10.1007/s10876-021-02104-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10876-021-02104-6